Table 2 Demographics of patients with Tolosa-Hunt syndrome
From: The clinical features and outcomes of Tolosa-Hunt syndrome
Parameters | |||
|---|---|---|---|
Total patients (n) | 11 | ||
Male : Female (n) | 9 (81.12 %) : 2 (18.18 %) | ||
Age at time of onset (years) | 57.18 ± 15.32 (range : 35–78) | ||
Involved eye (right : left) | 5 (45.45 %) : 6 (54.55 %) | ||
Duration of follow-up (days) | 201.27 ± 31.36 | ||
Duration of recovery (days) | 26.91 ± 24.35 (range : 8–73) | ||
Complete recovery state (n) | 10 (90.91 %) | ||
ESR (mm/hour) | 16.73 ± 13.76 (range : 2–52) | ||
CRP (mg/L) | 1.15 ± 0.84 (range : 0.3–2.6) | ||
Diplopia (n) | 11 (100 %) | ||
Periorbital pain (n) | 11 (100 %) | ||
CN nerve involvement cases (n) Optic nerve Third CN Fourth CN Trigeminal nerve Sixth CN | 2 (18.18 %) 5 (45.45 %) 5 (45.45 %) 1 (9.09 %) 8 (72.73 %) | ||
Ptosis (n) | 5 (45.45 %) | ||
Hypertension (n) | 3 (27.27 %) | ||
Diabetes mellitus (n) | 2 (18.18 %) | ||
Recurrence state (n) | 2 (28.18 %) | ||